|
|||||
|
|
Phase II Trial of Full-Dose Gemcitabine and Bevacizumab in Combination With Attenuated Three-Dimensional Conformal Radiotherapy in Patients With Localized Pancreatic Cancer |
|
| Authors: | William Small Jr. M.D. Mary F. Mulcahy M.D. Alfred Rademaker Ph.D. David J. Bentrem M.D. Al B. Benson M.D. Bing Bing Weitner M.S. Mark S. Talamonti M.D. |
| Affiliation: | a Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Chicago, Illinois |
| Abstract: | |
| Keywords: | Bevacizumab Gemcitabine Pancreatic cancer 3D conformal radiotherapy Survival |
| 本文献已被 ScienceDirect 等数据库收录！ | |